Colarusso, C.* et al. Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma. Oncotarget 12, 1057-1071 (2021)
Decker, T.-M. et al. Analog-sensitive cell line identifies cellular substrates of CDK9. Oncotarget 10, 6934-6943 (2019)
Li, Y.* et al. Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development. Oncotarget 10, 1760-1774 (2019)
Ingold, I. & Conrad, M. Selenium and iron, two elemental rivals in the ferroptotic death process. Oncotarget 9, 22241-22242 (2018)
Kazokaite, J.* et al. Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells. Oncotarget 9, 26800-26816 (2018)
von Olshausen, G.* et al. Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion. Oncotarget 9, 33947-33960 (2018)
Wȩglarz-Tomczak, E.* et al. Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs. Oncotarget 9, 29365-29378 (2018)
Azimzadeh, O. et al. A dose-dependent perturbation in cardiac energy metabolism is linked to radiation-induced ischemic heart disease in Mayak nuclear workers. Oncotarget 8, 9067-9078 (2017)
Chendeb, M.* ; Schneider, R. ; Davidson, I.* & Fadloun, A. Selective elimination of long INterspersed element-1 expressing tumour cells by targeted expression of the HSV-TK suicide gene. Oncotarget 8, 38239-38250 (2017)
Deppisch, N. ; Ruf, P.* ; Eißler, N. ; Lindhofer, H.* & Mocikat, R. Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition. Oncotarget 8, 4520-4529 (2017)
Fallik, N.* et al. Neat1 in hematopoietic stem cells. Oncotarget 8, 109575-109586 (2017)
Florea, A.M.* et al. Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma. Oncotarget 8, 22876-22893 (2017)
Garz, A.K.* et al. Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations. Oncotarget 8, 108738-108759 (2017)
Giopanou, I.* ; Lilis, I.* ; Papadaki, H.* ; Papadas, T.* & Stathopoulos, G.T. A link between ReIB expression and tumor progression in laryngeal cancer. Oncotarget 8, 114019-114030 (2017)
Hofer, P.* et al. Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas. Oncotarget 8, 98623-98634 (2017)
Jacobs, L.* et al. Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma. Oncotarget 8, 78917-78929 (2017)
Kleemann, M.* et al. Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis. Oncotarget 8, 18773-18791 (2017)
Krupka, C. et al. Targeting CD157 in AML using a novel, Fc-engineered antibody construct. Oncotarget 8, 35707-35717 (2017)
Kunzke, T. et al. Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome. Oncotarget 8, 68012-68025 (2017)
O'Leary, V.B. et al. The circRNA interactome-innovative hallmarks of the intra- and extracellular radiation response. Oncotarget 8, 78397-78409 (2017)
O'Leary, V.B. et al. The long non-coding RNA PARTICLE is associated with WWOX and the absence of FRA16D breakage in Osteosarcoma patients. Oncotarget 8, 87431-87441 (2017)
Ponce, L.P.* et al. SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cells. Oncotarget 8, 11284-11301 (2017)
Tsai, M.H.* et al. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers. Oncotarget 8, 10238-10254 (2017)
Vartholomaiou, E.* et al. Cytosolic Hsp90a and its mitochondrial isoform Trap1 are differentially required in a breast cancer model. Oncotarget 8, 17428-17442 (2017)
Wang, H.* ; Stoecklein, N.H.* ; Lin, P.P.* & Gires, O. Circulating and disseminated tumor cells: Diagnostic tools and therapeutic targets in motion. Oncotarget 8, 1884-1912 (2017)
Badie, C.* et al. Transcriptomic and proteomic analysis of mouse radiation-induced Acute Myeloid Leukaemia (AML). Oncotarget 7, 40461-40480 (2016)
Casciati, A.* et al. Age-related effects of X-ray irradiation on mouse hippocampus. Oncotarget 7, 28040-28058 (2016)
Dragoi, D. et al. Twist1 induces distinct cell states depending on TGFBR1-activation. Oncotarget 7, 30396-30407 (2016)
Engert, F.* ; Kovac, M.* ; Baumhoer, D.* ; Nathrath, M. & Fulda, S.* Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics. Oncotarget 8, 48794-48806 (2016)
Hensel, T.* et al. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. Oncotarget 7, 1451-1463 (2016)
Huber, M. et al. Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer. Oncotarget 7, 44062-44075 (2016)
John-Schuster, G. et al. Inflammaging increases susceptibility to cigarette smoke-induced COPD. Oncotarget 7, 30068-30083 (2016)
Kempf, S.J. et al. Chronic low-dose-rate ionising radiation affects the hippocampal phosphoproteome in the ApoE-/- Alzheimer's mouse model. Oncotarget 7, 71817-71832 (2016)
Niyazi, M. et al. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma. Oncotarget 7, 45764-45775 (2016)
Ott, C.A.* ; Linck, L.* ; Kremmer, E. ; Meister, G.* & Bosserhoff, A.K.* Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant melanoma cells. Oncotarget 7, 62292-62304 (2016)
Stojcheva, N.* et al. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget 7, 12937-12950 (2016)
Tanno, B.* et al. Ex vivo miRNome analysis in Ptch1+/- cerebellum granule cells reveals a subset of miRNAs involved in radiation-induced medulloblastoma. Oncotarget 7, 68253-68269 (2016)
Tepper, S.* et al. PARP activation promotes nuclear AID accumulation in lymphoma cells. Oncotarget 7, 13197-13208 (2016)
von Heyking, K.* et al. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma. Oncotarget 7, 41767-41780 (2016)
Ward-Caviness, C.K. et al. Long-term exposure to air pollution is associated with biological aging. Oncotarget 7, 74510-74525 (2016)
Wurster, S.* et al. PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response. Oncotarget 7, 9732-9741 (2016)
Falkenberg, N. et al. Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221. Oncotarget 6, 8103-8114 (2015)
Jacobi, C.* et al. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck. Oncotarget 6, 3462-3470 (2015)
Leinhäuser, I. et al. Oncogenic features of the Bone Morphogenic Protein 7 (BMP7) in pheochromocytoma. Oncotarget 6, 39111-39126 (2015)
Mancuso, M.* et al. Acceleration of atherogenesis in ApoE-/- mice exposed to acute or low-dose-rate ionizing radiation. Oncotarget 6, 31263-31271 (2015)
Nagel, D. et al. Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma. Oncotarget 6, 42232-42242 (2015)
Ribi, S.* et al. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome. Oncotarget 6, 7727-7740 (2015)
Teiluf, K.* et al. α-Radioimmunotherapy with 213Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma. Oncotarget 6, 4692-4703 (2015)
Walsh, K.M.* et al. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget 6, 42468-42477 (2015)
Xie, B.* et al. Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models. Oncotarget 6, 39036-39049 (2015)
Zhang, S.* et al. Anti-leukemic effects of the V-ATPase inhibitor Archazolid A. Oncotarget 6, 43508-43528 (2015)
Aichler, M. et al. Epidermal Growth Factor Receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. Oncotarget 5, 6620-6632 (2014)
Alachkar, H.* et al. Preclinical efficacy of Maternal Embryonic Leucine-zipper Kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget 5, 12371-12382 (2014)
Bedi, U.* ; Kumar Mishra, V.* ; Wasilewski, D. ; Scheel, C. & Johnsen, S.A.* Epigenetic plasticity: A central regulator of epithelial-tomesenchymal transition in cancer. Oncotarget 5, 2016-2029 (2014)
Keitel, U.* et al. Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation. Oncotarget 5, 11778-11791 (2014)
Litzenburger, U.M.* et al. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget 5, 1038-1051 (2014)
Neumann, M.* et al. Mutational spectrum of adult T-ALL. Oncotarget 6, 2754-2766 (2014)
Willimsky, G.* ; Protzer, U. ; Knolle, P.* & Heikenwälder, M. Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? Oncotarget 4, 1117-1118 (2013)
Hoos, A.* ; Wolf, M.J.* ; Bauer, J. ; Borsig, L.* & Heikenwälder, M. Endothelial chemokine receptors as facilitators of tumor cell extravasation? Oncotarget 3, 919-920 (2012)
Krappmann, D. Attacking MALT1 for ABC-DLBCL therapy. Oncotarget 3, 1489-1490 (2012)
Baumhoer, D. et al. CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients. Oncotarget 2, 970-975 (2011)
Hölzel, M. et al. The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: A double-edged sword. Oncotarget 1, 43-47 (2010)
Vucur, M.* et al. Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma? Oncotarget 1, 373-378 (2010)